BPG is committed to discovery and dissemination of knowledge
Retrospective Study Open Access
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Aug 19, 2026; 16(8): 118378
Published online Aug 19, 2026. doi: 10.5498/wjp.118378
Association between postoperative anxiety and depression symptoms and willingness for breast reconstruction in breast cancer patients
Xiao-Hu Sun, Xu-Chen Cao, The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China
Wen-Fu Shi, Department of Oncology and Hematology, Tianjin Beichen Traditional Chinese Medicine Hospital, Tianjin 300400, China
ORCID number: Xu-Chen Cao (0009-0003-1163-8931).
Co-first authors: Xiao-Hu Sun and Wen-Fu Shi.
Author contributions: Sun XH and Shi WF contributed equally to this work and share co-first authorship. Sun XH was responsible for study conception, data collection, and statistical analysis; Shi WF contributed to data collection and manuscript writing; Cao XC supervised the study design, critically revised the manuscript, and gave final approval of the version to be published. All authors read and approved the final manuscript.
Supported by the National Natural Science Foundation of China General Project, No. 32270810; and the Tianjin Key Medical Discipline Construction Project, No. TJYXZDXK-3-003A.
Institutional review board statement: Approved by the Research Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (No. EK2023375).
Informed consent statement: Informed consent was waived due to the retrospective design and use of anonymized data.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Data are available from the corresponding author upon reasonable request.
Corresponding author: Xu-Chen Cao, PhD, Chief Physician, The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huan-Hu Road, Ti Yuan Bei, Hexi District, Tianjin 300060, China. caoxuchen0907@126.com
Received: January 23, 2026
Revised: February 26, 2026
Accepted: March 27, 2026
Published online: August 19, 2026
Processing time: 187 Days and 23 Hours

Abstract
BACKGROUND

Breast cancer is the most frequently diagnosed malignancy in females globally, and total mastectomy commonly initiates substantial anxiety and depression symptomatology. Although previous studies have mainly evaluated breast reconstruction as a psychological intervention that achieves superior psychosocial outcomes, relatively limited research has investigated postoperative psychological distress as an influential factor in shaping patients’ cognition, attitudes and acceptance of reconstruction after mastectomy (especially from the perspective of Chinese patients, where a low rate of radical mastectomy being followed by immediate or delayed breast recon.

AIM

To investigate the prevalence of postoperative anxiety and depression symptoms in breast cancer patients and explore its associations with willingness, cognition, and attitudes toward breast reconstruction to provide evidence for improving mental health and quality of life.

METHODS

A total of 112 breast cancer patients receiving surgical management in Tianjin Medical University Cancer Institute and Hospital between October 2023 to October 2024 were enrolled in this retrospective study. The study utilized the Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) to measure anxiety and depression symptoms. Concurrently, patients Search of demand knowledge and comprehension based on breast reconstruction operative was explored. To analyze the correlations between anxiety-depression symptoms and willingness for breast reconstruction and their influencing factors, Pearson correlation analysis, multiple linear regression and multivariate logistic regression were performed.

RESULTS

Among 112 patients, the prevalence of anxiety symptoms was 42.86% (48/112), depression symptoms 39.29% (44/112), and anxiety-depression comorbidity 28.57% (32/112). The SAS score was 46.25 ± 10.82, and the SDS score was 48.73 ± 11.35. The cognition score for breast reconstruction was 18.73 ± 4.72, the attitude score was 44.82 ± 8.83, and the reconstruction intention rate was 32.14%. Correlation analysis showed that the SAS score was negatively correlated with the cognition score (r = -0.412, P < 0.01) and attitude score (r = -0.386, P < 0.01); the SDS score was negatively correlated with cognition score (r = -0.435, P < 0.01) and attitude score (r = -0.402, P < 0.01). Multiple regression analysis showed that anxiety-depression scores were independent negative influencing factors for cognition and attitude (P < 0.05). Logistic regression showed that anxiety score [odds ratio (OR) = 0.876, 95% confidence interval (CI): 0.812-0.945], cognition score (OR = 1.193, 95%CI: 1.040-1.461), and attitude score (OR = 1.340, 95%CI: 1.098-1.792) were independent predictors for reconstruction intention.

CONCLUSION

The prevalence of anxiety and depression symptoms in breast cancer patients after total mastectomy is high. Anxiety and depression symptoms are significantly associated with lower cognition levels and more negative attitudes, and demand for breast reconstruction. The more severe the anxiety and depression, the lower the cognition, the more negative the attitude, and the lower the willingness for reconstruction. Clinical practice should emphasize the assessment and intervention of mental health in breast cancer patients. Improving anxiety and depression symptoms may help enhance patients’ cognition and acceptance of breast reconstruction, ultimately improving quality of life.

Key Words: Breast cancer; Anxiety; Depression; Breast reconstruction; Cognition; Attitude; Mental health

Core Tip: Postoperative anxiety and depression are highly prevalent among breast cancer patients after total mastectomy and are strongly associated with reduced willingness for breast reconstruction. This study demonstrates that anxiety and depression negatively affect patients’ cognition and attitudes toward breast reconstruction, which in turn diminishes reconstruction intention. Patients with anxiety-depression comorbidity show the most pronounced decline. These findings highlight mental health as a modifiable factor in reconstruction decision-making and underscore the importance of integrating psychological assessment and intervention into routine breast cancer care to improve reconstruction acceptance and overall quality of life.



INTRODUCTION

Breast cancer is the most common malignant tumor among women globally, with approximately 2 million new cases annually and showing a trend toward younger age[1,2]. The management of the disorder is total mastectomy, which remains the most commonly adopted surgical approach as over 70% of patients undergo this surgery[3]. But breast loss not only impairs secondary sexual characteristics of women but also poses a huge psychological crisis to the patients. The accompanying symptoms of anxiety and depression are even more pronounced than those of the malignant tumor itself[4,5]. In breast cancer, a comparison of the baseline relationship and symptom or quality life between breast cancer patients as compared with that of the general population evidenced that there had been marked an extremely high incidence rate of develop anxiety and depression symptoms[6]. Breast loss has a considerable impact on patients’ body image, self-esteem and self-confidence, and hence causes a great psychological distress[7,8]. The existing literature has focused largely on the former-namely, breast reconstruction as an intervention that can improve psychological outcomes; however, a much smaller body of work has examined this question in reverse by addressing how patients’ postoperative psychological states (such as anxiety and depression), influence patient reflections on and interest in undergoing-breast reconstruction following mastectomy[9]. Anxiety and depression symptoms not only affect patients’ treatment compliance and recovery process but may also directly impact patients’ cognitive ability, attitude formation, and decision-making process regarding breast reconstruction. Patients with anxiety and depression often exhibit cognitive bias, negative thinking, and decision-making difficulties, which may lead to insufficient cognition and negative attitudes toward breast reconstruction, thereby missing opportunities to improve quality of life[10].

Breast reconstruction surgery is an effective measure to improve physical appearance and restore physical and mental health[11]. Research confirms that breast reconstruction does not increase the risk of recurrence or metastasis; rather, it is closely related to improvements in quality of life, body image, sexual behavior, and emotional health[12]. The post-reconstruction rate of breast cancer patients in the United States has exceeded 50%[13,14], but the reconstruction rate in China remains at a relatively low level[15]. Currently, research on the relationship between anxiety-depression symptoms and willingness for breast reconstruction is relatively limited. Previous studies have mostly focused on the improving effect of breast reconstruction on psychology, while less attention has been paid to how preoperative anxiety and depression status affect patients’ cognition and decision-making regarding breast reconstruction. If anxiety and depression symptoms indeed reduce patients’ cognition and acceptance of breast reconstruction, then preoperative psychological intervention may become a key strategy for improving reconstruction rates and improving patient outcomes. Therefore, this study aims to investigate the occurrence of postoperative anxiety and depression symptoms in breast cancer patients and their correlations with breast reconstruction cognition, attitudes, and demand, providing a scientific basis for formulating targeted psychological intervention measures.

MATERIALS AND METHODS
Study design and participants

This study employed a retrospective design and collected data from 112 breast cancer patients at the Breast Surgery Department of Tianjin Medical University Cancer Institute and Hospital from October 2023 to October 2024. Inclusion criteria: (1) Female patients with first-time diagnosed breast cancer; (2) Patients requiring total mastectomy; (3) Age ≥ 18 years; and (4) Ability to independently complete questionnaire surveys. Exclusion criteria: (1) Patients requesting breast-conserving surgery; (2) Patients unable to participate in surveys due to visual, auditory, or cognitive impairments; (3) Patients with other malignant tumors; (4) Patients with abnormal function of vital organs; and (5) Patients with a history of mental illness or currently taking psychiatric medications. This study was approved by the Ethics Committee, and all patients provided informed consent.

Mental health assessment

The Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) were used to assess patients’ anxiety and depression symptoms[16]. The SAS contains 20 items using a 4-point Likert scale, with a standard score ≥ 50 indicating anxiety symptoms (50-59 mild, 60-69 moderate, ≥ 70 severe). The SDS also contains 20 items, with a standard score ≥ 53 indicating depression symptoms (53-62 mild, 63-72 moderate, ≥ 73 severe). Both scales have good reliability and validity in the Chinese population[17], with Cronbach’s α coefficients of 0.89 and 0.88 in this study, respectively.

Breast reconstruction cognition and attitude assessment

The “survey questionnaire on demand, cognition, and attitude toward breast reconstruction surgery” was used for assessment[18]. The cognition questionnaire includes 6 items (total score 6-30), assessing patients’ understanding of breast reconstruction. The attitude questionnaire includes 15 items (total score 15-75, including negative and positive attitude items), assessing patients’ attitude tendencies toward breast reconstruction. A 5-point Likert scale was used, with higher scores indicating better cognitive level and more positive attitudes. The Cronbach’s α coefficients of the questionnaires were 0.89 and 0.87, respectively.

Statistical analysis

SPSS 26.0 statistical software was used. Measurement data were expressed as mean ± SD, and a t-test or analysis of variance was used to compare differences between groups. Count data were expressed as a n (%), and the χ2 test was used. Pearson correlation analysis was used to explore the correlations between anxiety-depression scores and breast reconstruction cognition and attitudes. Multiple linear regression was used to analyze the influencing factors of anxiety-depression symptoms, cognition, and attitudes. Multivariate logistic regression was used to analyze influencing factors of breast reconstruction intention[19]. For multivariate models, variables with P < 0.1 in univariate analysis or of prior clinical relevance were entered into the initial models. Given that 36 patients reported reconstruction intention with five predictors in the logistic model, the events-per-variable ratio approximates 7, which falls at the lower boundary of conventional recommendations; findings should therefore be interpreted with appropriate caution and replicated in larger samples. Because multiple correlation and regression analyses were conducted, no formal correction for multiple comparisons (e.g., Bonferroni) was applied, and results at the P < 0.05 threshold should be treated as exploratory. P < 0.05 was considered statistically significant.

RESULTS
General characteristics of study participants

A total of 112 breast cancer patients were enrolled, with a mean age of 52.83 ± 5.92 years and BMI of 23.98 ± 6.02 kg/m2. Married patients numbered 96 (85.71%), those with bachelor’s degree or above 28 (25.00%), employed patients 52 (46.43%), and urban residents 64 (57.14%). Patients with smoking history numbered 12 (10.71%), drinking history 18 (16.07%), comorbid chronic diseases 36 (32.14%), and family history of breast cancer 8 (7.14%) (Table 1).

Table 1 General characteristics of study participants, n (%).
Characteristics
Statistics
Age (years)52.83 ± 5.92
BMI (kg/m2)23.98 ± 6.02
Gender - female112 (100.0)
Marital status - married96 (85.71)
Education - Bachelor’s or above28 (25.00)
Employed52 (46.43)
Urban residents64 (57.14)
Smoking history12 (10.71)
Drinking history18 (16.07)
Comorbid chronic diseases36 (32.14)
Family history of breast cancer8 (7.14)
Prevalence of anxiety and depression symptoms in breast cancer patients

The SAS score of 112 patients was 46.25 ± 10.82, and the SDS score was 48.73 ± 11.35. According to diagnostic criteria, the prevalence of anxiety symptoms was 42.86% (48/112), including mild anxiety in 36 patients (32.14%), moderate in 10 patients (8.93%), and severe in 2 patients (1.79%). The prevalence of depression symptoms was 39.29% (44/112), including mild depression in 32 patients (28.57%), moderate in 10 patients (8.93%), and severe in 2 patients (1.79%). The prevalence of anxiety-depression comorbidity was 28.57% (32/112) (Table 2).

Table 2 Prevalence of anxiety and depression symptoms, n (%).
Psychological symptoms
Score
Prevalence
Anxiety symptoms (SAS)46.25 ± 10.8248 (42.86)
Mild anxiety36 (32.14)
Moderate anxiety10 (8.93)
Severe anxiety2 (1.79)
Depression symptoms (SDS)48.73 ± 11.3544 (39.29)
Mild depression32 (28.57)
Moderate depression10 (8.93)
Severe depression2 (1.79)
Anxiety-depression comorbidity32 (28.57)
Comparison of patient characteristics between anxiety and non-anxiety groups

Patients were divided into the anxiety group (n = 48) and the non-anxiety group (n = 64) based on the SAS score. In terms of mental health, the SDS score in the anxiety group (56.42 ± 9.87) was significantly higher than that in the non-anxiety group (42.94 ± 8.26) (P < 0.001), indicating that anxiety and depression symptoms often coexist. The prevalence of depression symptoms in the anxiety group was 75.00% (36/48), significantly higher than 12.50% (8/64) in the non-anxiety group (P < 0.001). Regarding breast reconstruction indicators, the cognition score in the anxiety group (15.83 ± 4.26) was significantly lower than that in the non-anxiety group (20.88 ± 3.95) (P < 0.001). The attitude score in the anxiety group (39.67 ± 7.84) was significantly lower than that in the non-anxiety group (48.75 ± 7.62) (P < 0.001). The proportion of patients with reconstruction intention in the anxiety group was 16.67% (8/48), significantly lower than 43.75% (28/64) in the non-anxiety group (P = 0.027). These results indicate that anxiety symptoms significantly reduced patients’ cognitive level, positive attitudes, and willingness for breast reconstruction (Table 3).

Table 3 Comparison of patient characteristics between anxiety and non-anxiety groups, n (%).
Indicators
Anxiety group (n = 48)
Non-anxiety group (n = 64)
P value
SDS score56.42 ± 9.8742.94 ± 8.26< 0.001
Depression prevalence36 (75.00)8 (12.50)< 0.001
Cognition score15.83 ± 4.2620.88 ± 3.95< 0.001
Attitude score39.67 ± 7.8448.75 ± 7.62< 0.001
Reconstruction intention8 (16.67)28 (43.75)0.027
Mean age (years)54.67 ± 5.3851.50 ± 5.940.036
Comparison of breast reconstruction cognition and attitudes among patients with different psychological states

Patients were divided into a normal group (n = 40), an anxiety-only group (n = 16), a depression-only group (n = 12), and an anxiety-depression comorbidity group (n = 32). Cognition scores showed a significant gradient change: Normal group (22.35 ± 3.42) > anxiety-only group (18.25 ± 3.86) > depression-only group (17.83 ± 4.12) > anxiety-depression comorbidity group (14.19 ± 3.75) (F = 18.74, P < 0.001). Attitude scores also showed a gradient change: Normal group (50.85 ± 6.92) > anxiety-only group (42.75 ± 7.34) > depression-only group (41.67 ± 7.89) > anxiety-depression comorbidity group (36.25 ± 6.58) (F = 16.92, P < 0.001). Reconstruction intention rate: Normal group 55.00% > anxiety-only group 25.00% > depression-only group 16.67% > anxiety-depression comorbidity group 6.25% (P = 0.005). This clearly demonstrates the negative impact of anxiety and depression symptoms on patients’ breast reconstruction cognition, attitudes, and demand, with the most severe impact on comorbid patients (Table 4).

Table 4 Comparison of breast reconstruction cognition and attitudes among patients with different psychological states.
Indicators
Normal (n = 40)
Anxiety-only (n = 16)
Depression-only (n = 12)
Comorbidity (n = 32)
P value
Cognition score22.35 ± 3.4218.25 ± 3.8617.83 ± 4.1214.19 ± 3.75< 0.001
Attitude score50.85 ± 6.9242.75 ± 7.3441.67 ± 7.8936.25 ± 6.58< 0.001
Reconstruction intention (%)55.0025.0016.676.250.005
SAS score42.15 ± 6.2354.38 ± 4.1243.67 ± 5.8959.88 ± 8.45< 0.001
SDS score44.23 ± 5.6746.85 ± 6.1256.92 ± 7.3461.45 ± 9.12< 0.001
Correlation analysis between anxiety-depression scores and breast reconstruction cognition and attitudes

Pearson correlation analysis showed that the SAS score was significantly negatively correlated with cognition score (r = -0.412,P = 0.002) and attitude score (r = -0.386, P = 0.003). SDS score was significantly negatively correlated with cognition score (r = -0.435, P = 0.001) and attitude score (r = -0.402, P = 0.002). This indicates that the more severe the patients’ anxiety and depression, the lower their cognitive level regarding breast reconstruction and the more negative their attitudes (Table 5). In the anxiety-depression comorbidity group, the correlation was more significant: SAS score with cognition score r = -0.528 (P = 0.034), with attitude score r = -0.491 (P = 0.051, approaching statistical significance); SDS score with cognition score r = -0.562 (P = 0.022), with attitude score r = -0.517 (P = 0.041). This suggests that in comorbid patients, the negative impact of psychological symptoms on breast reconstruction cognition and attitudes is more pronounced, possibly requiring more aggressive psychological intervention.

Table 5 Correlation analysis between anxiety-depression scores and breast reconstruction cognition and attitudes.
Variables
Cognition score
Attitude score
SAS scorer = -0.412, P = 0.002br = -0.386, P = 0.003b
SDS scorer = -0.435, P = 0.001br = -0.402, P = 0.002b
Ager = -0.325, P = 0.014ar = -0.298, P = 0.025a
Education levelr = 0.418, P = 0.001br = 0.385, P = 0.003b
Employment statusr = 0.312, P = 0.018ar = 0.341, P = 0.012a
Multiple linear regression analysis of the influencing factors of anxiety and depression symptoms

Multiple linear regression analysis with SAS score as the dependent variable showed (F = 32.86, P < 0.001, adjusted R2 = 0.742): Age (β = 0.412, P = 0.003) and lymph node metastasis (β = 3.758, P = 0.024) were risk factors for anxiety; employment status (β = -4.327, P = 0.012), bachelor’s degree or above (β = -5.186, P = 0.007), and urban residence (β = -3.942, P = 0.018) were protective factors. Multiple linear regression analysis with SDS score as the dependent variable showed (F = 28.94, P < 0.001, adjusted R2 = 0.716): Age (β = 0.387, P = 0.006) and comorbid chronic diseases (β = 4.023, P = 0.028) were risk factors for depression; employment status (β = -4.681, P = 0.009), bachelor’s degree or above (β = -5.524, P = 0.005), and urban residence (β = -4.215, P = 0.014) were protective factors (Figure 1).

Figure 1
Figure 1 Multiple linear regression analysis of factors influencing postoperative anxiety and depression in breast cancer patients following total mastectomy. A: Influencing factors of anxiety; B: Influencing factors of depression. Orange circles indicate risk factors (β > 0) and purple circles indicate protective factors (β < 0). Standardized beta coefficients (β) with corresponding P-values are shown for each variable. Both models demonstrated good fit (A: F = 32.86, P < 0.001, adjusted R2 = 0.742; B: F = 28.94, P < 0.001, adjusted R2 = 0.716). SAS: Self-Rating Anxiety Scale; SDS: Self-Rating Depression Scale.
Analysis of influencing factors of breast reconstruction cognition and attitudes

Regression analysis of cognition score showed (F = 42.78, P < 0.001, adjusted R2 = 0.826): Age had a negative impact on cognition (β = -0.128, P = 0.042); monthly family income ≥ 20000 yuan (β = 0.204, P = 0.018), bachelor’s degree or above (β = 0.372, P = 0.001), and urban residence (β = 0.402, P < 0.001) were promoting factors; SAS score had a significant negative impact on cognition (β = -0.186, P = 0.006), and SDS score also had a negative impact on cognition (β = -0.195, P = 0.004). Regression analysis of attitude score showed (F = 38.64, P < 0.001, adjusted R2 = 0.802): Employment status (β = 0.234, P = 0.008), bachelor’s degree or above (β = 0.209, P = 0.014), and urban residence (β = 0.283, P = 0.002) were promoting factors; SAS score had a significant negative impact on attitude (β = -0.172, P = 0.012), and SDS score also had a negative impact on attitude (β = -0.188, P = 0.008). This confirms that after controlling for other factors, anxiety and depression symptoms remain independent predictors for patients' breast reconstruction cognition and attitudes (Figure 2).

Figure 2
Figure 2 Comparison of standardized beta coefficients for factors influencing anxiety (Self-Rating Anxiety Scale, blue) and depression (Self-Rating Depression Scale, orange) symptoms. Positive β values indicate risk factors, and negative β values indicate protective factors. Lymph node metastasis and comorbid chronic diseases were identified as risk factors, while employment status, bachelor’s degree or above, and urban residence were protective factors for both anxiety and depression (Self-Rating Anxiety Scale: F = 32.86, R2 = 0.742; Self-Rating Depression Scale: F = 28.94, R2 = 0.716). SAS: Self-Rating Anxiety Scale; SDS: Self-Rating Depression Scale.
Logistic regression analysis of influencing factors of breast reconstruction intention

Logistic regression analysis with whether there was breast reconstruction intention as the dependent variable was performed (χ2 = 38.72, P < 0.001, Nagelkerke R2 = 0.658). Results showed: Age was negatively associated with willingness for breast reconstruction [odds ratio (OR) = 0.893, 95% confidence interval (CI): 0.834-0.972, P = 0.007]; SAS score was a protective factor (OR = 0.876, 95%CI: 0.812-0.945, P < 0.001), with each 1-point increase in anxiety score, the likelihood of having reconstruction intention decreased by 12.4%; cognition score was a risk factor (OR = 1.193, 95%CI: 1.040-1.461, P = 0.015); attitude score was a risk factor (OR = 1.340, 95%CI: 1.098-1.792, P = 0.006) (Table 6). It is noteworthy that the SDS score did not enter the final model (P = 0.124), which may be due to strong collinearity between the SAS and SDS scores (r = 0.782, P < 0.001). This suggests anxiety and depression symptoms often coexist and have a synergistic negative impact on breast reconstruction intention.

Table 6 Logistic regression analysis of influencing factors of breast reconstruction intention1.
Variables
β
OR
95%CI
P value
Age-0.1140.8930.834-0.9720.007
SAS score-0.1320.8760.812-0.945< 0.001
Cognition score0.1761.1931.040-1.4610.015
Attitude score0.2931.3401.098-1.7920.006
Education level0.1981.2191.056-1.4070.007
DISCUSSION

This simply retrospective study discovered a relatively higher prices of anxiousness and despair signs in breast cancer sufferers after complete mastectomy (anxiety 42.86%; depression 39.29%; comorbidity 28.57%) than the final inhabitants. More notably, this study provided a systematic demonstration of a powerful negative correlation between anxiety-depression symptoms and breast reconstruction cognition, attitudes and demands in patients for the first time. Severe anxiety and depression results in relative lower cognitive level of the patients concerning breast reconstruction, negative attitude and poor willingness for reconstruction. The clinical relevance of this finding was also clear, as preoperative mental health assessment and intervention may represent a key opportunity to improve reconstruction rates and ultimately patient outcomes.

Several perspectives can largely explain the high levels of anxiety and depression identified in this study. In psychosocial terms, loss of a breast attacks patients’ body integrity, damage their sex appeal as well as feminine identity and may contribute to body image disturbance and low self-esteem[20,21]. Neurobiologically, in the cancer situation, activation of hypothalamic-pituitary-adrenal axis brings about elevated cognate corticoid secretion. Hippocampal atrophy and reduced neuroplasticity are crucial mechanisms in the pathophysiology of depression, which is associated with chronic elevation of cortisol[22]. In-terms of inflammation, cancer and its treatment leads to self-perpetuating inflammatory responses, and high levels of pro-inflammatory cytokines can evoke depressive symptoms by altering neurotransmitter metabolism[23,24].

Data support a sequential, mutually reinforcing mechanistic pathway over parallel independent effects. Anxiety preferentially channels attentional resources towards surgical risk and adverse outcomes, a closely studied threat-related attentional bias[25], while at the same time exhausting cognitive bandwidth for processing reconstructive information dispassionately. Clinically, this finding is represented in our sample with the high levels of fear about cancer prognosis (91.67%) and uncertainty about surgery success rates (87.50%). At multiple levels depression is superimposed: Impaired concentration and memory (66.67% reported difficulty concentrating while 77.27% complained of fatigue[26]) limits the patient ability to integrate new information, while an Hedonia and reduced motivation suppressed the need to seek out reconstructive options[27]. At the schema level, core beliefs of hopelessness - particularly pessimism about the future (68.18%) and reduced self-evaluation (72.73%) - weaken expectations regarding benefits of reconstruction before attitudinal deliberation[28,29]. More importantly, the mechanisms do not act in isolation: Anxiety-driven attentional bias corrupts the information environment, depression-driven cognitive impairment restricts processing capacity, and negative schemata inhibit motivational engagement - each step escalating to the next stage of disillusion with attitudes; and yielding the large attitude deficits we observe in the anxiety, depression comorbidity group (attitude score 36.25 ± 6.58 vs normal group 50.85 ± 6.92)[30].

Logistic regression revealed a mediating mechanism: Anxiety score itself is a protective factor (negative impact) for reconstruction intention, while cognition and attitude scores are risk factors (positive impact). This suggests anxiety-depression symptoms may affect reconstruction intention through direct and indirect pathways[31]. In the direct pathway, anxiety-depression symptoms cause patients to lack motivation to pursue an improved quality of life. In the indirect pathway, anxiety and depression first reduce cognition and attitudes, and low cognition and negative attitudes further reduce reconstruction intention. This finding has important implications for clinical practice: Merely providing reconstruction information may not be sufficient to improve reconstruction rates; anxiety and depression symptoms must be improved simultaneously.

The mechanistic account above has direct implications for clinical practice that extend beyond general recommendations for psychological support. Because anxiety and depression appear to distort information processing prior to attitude formation and because our logistic model demonstrates that attitudes, in turn, mediate reconstruction intention - the sequencing of clinical intervention is critical: Psychological assessment and treatment must logically precede, rather than merely accompany, the delivery of reconstructive information[32]. This means that routine preoperative SAS and SDS screening must be not an add-on, but a gate-keeping stage linking patients identified as high risk with evidence-based psychological intervention (e.g., cognitive bias modification to alleviate negative schemata[33] or mindfulness-based stress reduction to restore capacity for regulatory functions[34]) before reconstructive therapeutic counseling commences. The approach therefore is individualized, staged health education (stages of change)-a direct consequence of the cognitive resource depletion mechanism: Patients whose processing capacity is compromised by depression are unable to absorb comprehensive reconstruction information delivered all at once, requiring graduated, capacity-matched delivery[35]. Finally, as our data identify age[36], low education[37], rural residence and limited income[38,39] as independent correlates of greater psychological distress and poorer reconstruction cognition, a multidisciplinary team including breast surgeons, plastic surgeons, psychological counselors and special nurses - should provide additional targeted support to these subgroups whose attitudinal and cognitive deficits are compounded by structural disadvantage[40]. So all the recommendations that follow are not separate recommendations, but rather be evidence-based consequences to an actionable pathway from a specific identified pathway corresponding part in the anxiety-depression-cognition-attitude-demand chain. These results build on earlier findings, as they illustrate an inverse pathway from psychological distress to reconstruction decision making.

Limitations

There are some limitations to this study that deserve attention. While this is an important study, there are limitations: First, the cross-sectional design, a retrospective survey, inherently precludes any ascertainment of causal or temporal associations between psychological measure and reconstruction perception, and the entire discussion has been adjusted throughout to reflect that these findings should be viewed associatively rather than predictively. Second, the single-center design of a tertiary oncology hospital may have enrolled a more medically complex patient population that would be seen in lower-resource or community settings and limit generalizability. Next steps should utilize large-sample, multicenter prospective designs with formal reconstruction candidacy assessment, oncological staging variables and long-term follow-up on actual receipt of rebuilding.

CONCLUSION

It can effectively improve patients’ anxiety and depression symptoms, cognitive level and attitude to breast reconstruction, promote the acceptance of breast reconstruction in the short term, and ultimately change the body image of breast cancer patients from “survival” to “living”, improve self-esteem or self-confidence quality of life.

References
1.  Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10-45.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1828]  [Cited by in RCA: 2427]  [Article Influence: 2427.0]  [Reference Citation Analysis (11)]
2.  Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72:524-541.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1631]  [Cited by in RCA: 1367]  [Article Influence: 341.8]  [Reference Citation Analysis (0)]
3.  Flynn MA, Eggerth DE, Jacobson CJ Jr, Lyon SM. Heart Attacks, Bloody Noses, and Other "Emotional Problems": Cultural and Conceptual Issues With the Spanish Translation of Self-Report Emotional Health Items. Fam Community Health. 2021;44:1-9.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 3]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
4.  Wang J, Kang DX, Zhang AJ, Li BR. Effects of psychological intervention on negative emotions and psychological resilience in breast cancer patients after radical mastectomy. World J Psychiatry. 2024;14:8-14.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in CrossRef: 11]  [Cited by in RCA: 8]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
5.  Penberthy JK, Stewart AL, Centeno CF, Penberthy DR. Psychological Aspects of Breast Cancer. Psychiatr Clin North Am. 2023;46:551-570.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 21]  [Reference Citation Analysis (0)]
6.  Munhoz AM, Montag E, Arruda E, Okada A, Brasil JA, Gemperli R, Filassi JR, Ferreira MC. Immediate locally advanced breast cancer and chest wall reconstruction: surgical planning and reconstruction strategies with extended V-Y latissimus dorsi myocutaneous flap. Plast Reconstr Surg. 2011;127:2186-2197.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 19]  [Cited by in RCA: 19]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
7.  Thakur M, Sharma R, Mishra AK, Singh K, Kar SK. Psychological distress and body image disturbances after modified radical mastectomy among breast cancer survivors: A cross-sectional study from a tertiary care centre in North India. Lancet Reg Health Southeast Asia. 2022;7:100077.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 39]  [Cited by in RCA: 29]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
8.  Adelson PD, Srinivas R, Chang Y, Bell M, Kochanek PM. Cerebrovascular response in children following severe traumatic brain injury. Childs Nerv Syst. 2011;27:1465-1476.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 74]  [Cited by in RCA: 60]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
9.  Storey RF, Valgimigli M, Cuisset T, Capodanno D, Wijns W, Knuuti J. Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelines. Eur Heart J. 2020;41:483-484.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 3]  [Cited by in RCA: 4]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
10.  Kobayashi S, Nakachi K, Ikeda M, Konishi M, Ogawa G, Sugiura T, Yanagimoto H, Morinaga S, Wada H, Shimada K, Takahashi Y, Nakagohri T, Kamata K, Shimizu Y, Ajiki T, Hirano S, Gotohda N, Ueno M, Okusaka T, Furuse J. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202. Eur J Surg Oncol. 2024;50:107324.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 5]  [Cited by in RCA: 6]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
11.  Keshavarz M, Javanmardi F, Mohammdi AA. A Decade Epidemiological Study of Pediatric Burns in South West of Iran. World J Plast Surg. 2020;9:67-72.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
12.  Tomita S, Yoshitake T, Matsunaga N, de Kerckhove M, Fujii M, Terao Y. Patient-reported outcomes and quality of life after breast-conserving surgery, mastectomy, and breast reconstruction assessed using the BREAST-Q questionnaire. Breast Cancer Res Treat. 2024;207:641-648.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 11]  [Reference Citation Analysis (0)]
13.  Pratt MD, Mufti A, Lipson J, Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Zirwas MJ, Fransway AF, Mathias CG, Zug KA, DeLeo VA, Fowler JF Jr, Marks JG, Storrs FJ, Belsito DV. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014. Dermatitis. 2017;28:58-63.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 19]  [Cited by in RCA: 25]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
14.  Hwang HW, Jung H, Hyeon J, Park YH, Ahn JS, Im YH, Nam SJ, Kim SW, Lee JE, Yu JH, Lee SK, Choi M, Cho SY, Cho EY. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients. Breast Cancer Res Treat. 2019;173:255-266.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 108]  [Cited by in RCA: 102]  [Article Influence: 14.6]  [Reference Citation Analysis (0)]
15.  Canadell JG, Poulter B, Bastos A, Ciais P, Hauck J, Andrew R, Friedlingstein P, Grassi G, Jackson RB, Müller JD, Le Quéré C, O'Sullivan M, Patra P, Peters GP, Pongratz J, Saunois M, Sitch S, Tian H, Villalobos Y, Wang X. From global to national GHG budgets: the REgional Carbon Cycle Assessment and Processes-3 (RECCAP3). Natl Sci Rev. 2025;12:nwaf037.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
16.  Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12:371-379.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 3461]  [Cited by in RCA: 2998]  [Article Influence: 54.5]  [Reference Citation Analysis (1)]
17.  Dunstan DA, Scott N. Norms for Zung's Self-rating Anxiety Scale. BMC Psychiatry. 2020;20:90.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 446]  [Cited by in RCA: 410]  [Article Influence: 68.3]  [Reference Citation Analysis (1)]
18.  Wei X, Ye P, Chen L, Tang H, Yin W, Shao M, Bai R, Li Y, Yu J, Wang W, Zhang J. Knowledge, Attitudes, and Practices of Chinese Breast Cancer Patients Towards Comprehensive Postoperative Self-Management: a Cross-Sectional Study. J Multidiscip Healthc. 2025;18:1923-1934..  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
19.  Hosmer DW, Lemeshow S, Sturdivant RX.   Applied Logistic Regression. 3rd ed. Hoboken: Wiley, 2013.  [PubMed]  [DOI]  [Full Text]
20.  Falk Dahl CA, Reinertsen KV, Nesvold IL, Fosså SD, Dahl AA. A study of body image in long-term breast cancer survivors. Cancer. 2010;116:3549-3557.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 151]  [Cited by in RCA: 172]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
21.  Begovic-Juhant A, Chmielewski A, Iwuagwu S, Chapman LA. Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol. 2012;30:446-460.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 95]  [Cited by in RCA: 123]  [Article Influence: 8.8]  [Reference Citation Analysis (0)]
22.  Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26:971-982.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 490]  [Cited by in RCA: 444]  [Article Influence: 24.7]  [Reference Citation Analysis (6)]
23.  Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22-34.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 3262]  [Cited by in RCA: 2913]  [Article Influence: 291.3]  [Reference Citation Analysis (4)]
24.  Weth D, Benetti C, Rauch C, Gstraunthaler G, Schmidt H, Geisslinger G, Sabbadini R, Proia RL, Kress M. Activated platelets release sphingosine 1-phosphate and induce hypersensitivity to noxious heat stimuli in vivo. Front Neurosci. 2015;9:140.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 9]  [Cited by in RCA: 11]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
25.  Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, van IJzendoorn MH. Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol Bull. 2007;133:1-24.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2917]  [Cited by in RCA: 2441]  [Article Influence: 128.5]  [Reference Citation Analysis (0)]
26.  Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029-2040.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1780]  [Cited by in RCA: 1554]  [Article Influence: 129.5]  [Reference Citation Analysis (1)]
27.  Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35:537-555.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1136]  [Cited by in RCA: 1135]  [Article Influence: 75.7]  [Reference Citation Analysis (0)]
28.  Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 2008;165:969-977.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1220]  [Cited by in RCA: 972]  [Article Influence: 54.0]  [Reference Citation Analysis (3)]
29.  Abramson LY, Metalsky GI, Alloy LB. Hopelessness depression: A theory-based subtype of depression. Psychol Rev. 1989;96:358-372.  [PubMed]  [DOI]  [Full Text]
30.  Mathews A, Mackintosh B. A cognitive model of selective processing in anxiety. Cognit Ther Res. 1998;22:539-560.  [PubMed]  [DOI]  [Full Text]
31.  Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191-215.  [PubMed]  [DOI]  [Full Text]
32.  Beck AT, Haigh EA. Advances in cognitive theory and therapy: the generic cognitive model. Annu Rev Clin Psychol. 2014;10:1-24.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 719]  [Cited by in RCA: 491]  [Article Influence: 40.9]  [Reference Citation Analysis (0)]
33.  Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006;29:17-27.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 218]  [Cited by in RCA: 203]  [Article Influence: 10.2]  [Reference Citation Analysis (0)]
34.  Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003;65:571-581.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 502]  [Cited by in RCA: 419]  [Article Influence: 18.2]  [Reference Citation Analysis (3)]
35.  Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31:782-793.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 510]  [Cited by in RCA: 565]  [Article Influence: 43.5]  [Reference Citation Analysis (0)]
36.  Álvarez-Pardo S, de Paz JA, Romero-Pérez EM, Tánori-Tapia JM, Rendón-Delcid PA, González-Bernal JJ, Fernández-Solana J, Simón-Vicente L, Mielgo-Ayuso J, González-Santos J. Related Factors with Depression and Anxiety in Mastectomized Women Breast Cancer Survivors. Int J Environ Res Public Health. 2023;20:2881.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 3]  [Cited by in RCA: 17]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
37.  Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155:97-107.  [PubMed]  [DOI]  [Full Text]
38.  Le NK, Gabrick KS, Chouairi F, Mets EJ, Avraham T, Alperovich M. Impact of socioeconomic status on psychological functioning in survivorship following breast cancer and reconstruction. Breast J. 2020;26:1695-1701.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 17]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
39.  Delamerced J, Ramirez L, Kimberly JA, Vargas SI, Flanigan TP, Sanchez MC, Bruciati K, So-Armah K. Going to the Source: Discussions With Early and Mid-Career Faculty From Groups Underrepresented in Biomedical Research to Develop and Enhance CFAR Services. J Acquir Immune Defic Syndr. 2023;94:S108-S115.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 2]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
40.  Lyvers M, Dark S, Jaguru I, Thorberg FA. Adult symptoms of ASD and ADHD in relation to alcohol use: Potential roles of transdiagnostic features. Alcohol. 2024;120:109-117.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 4]  [Cited by in RCA: 3]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
Footnotes

Peer review: Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Psychiatry

Country of origin: China

Peer-review report’s classification

Scientific quality: Grade B, Grade C

Novelty: Grade B, Grade C

Creativity or innovation: Grade B, Grade B

Scientific significance: Grade C, Grade C

P-Reviewer: Gawry M, PhD, Poland; Song IU, PhD, South Korea S-Editor: Bai SR L-Editor: A P-Editor: Lei YY

Write to the Help Desk